ZCMD

Zhongchao Inc.
CAPPED RATING

Zhongchao Inc. (ZCMD) is rated C- (2.1/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B); its weakest is Growth (F).

Quantitative Factor Evaluation • Updated

Overall Rating
2.1 / 5.0
C-
Value
B
Factor Score 3.3 / 5.0
Growth
F
Factor Score 0.3 / 5.0
Profitability
B
Factor Score 3.4 / 5.0
Momentum
F
Factor Score 0.7 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA 1.4
Rev Growth YoY -85.0%
Gross Margin 37.3%
Price Return 3M -57.5%
Price Return 12M -99.9%
Catalyst Signal 0.00
Market Cap $4.0M
TTM Revenue $6.6M
Price / Sales 0.6
ROE -42.6%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-15 B (3.3) F (0.3) B (3.4) F (0.7) C+ (2.6) C- (2.1)
2026-11-08 B (3.4) F (0.2) B- (3.0) F (0.7) C+ (2.6) C- (2.0)
2026-11-01 B (3.3) D (1.2) B+ (3.5) F (0.7) C+ (2.7) C (2.3)
2026-10-25 B (3.3) D (1.2) B+ (3.5) D- (0.7) C+ (2.6) C (2.3)
2026-10-18 B (3.3) D (1.2) B+ (3.5) F (0.6) C+ (2.6) C (2.3)
Page 1 of 4